BKSW — Baikang Biological group Balance Sheet
0.000.00%
Last trade - 00:00Consumer DefensivesMicro Cap
Annual balance sheet for Baikang Biological group, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2017 April 30th | 2018 April 30th | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 0.449 | 0.743 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 1.32 | 3.67 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 9.65 | 13.4 |
| Net Intangible Assets | ||
| Other Long Term Assets | ||
| Total Assets | 13.3 | 18 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 19.7 | 8.81 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Minority Interest | ||
| Total Liabilities | 19.7 | 9.45 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | -6.36 | 8.55 |
| Total Liabilities & Shareholders' Equity | 13.3 | 18 |
| Total Common Shares Outstanding |